Caixa Capital Risc
iPRONICS, the pioneering photonic computing company that has developed the first general-purpose photonic processor that is reconfigurable by software, today announced a €3.7M investment led by Amadeus Capital Partners, with participation from Caixa Capital Risc. Emerging technology trends in autonomous vehicles and LIDAR, 5G signal processing, deep learning and AI, cyber security, DNA sequencing, and […]
Minoryx raises €51 million to support Marketing Authorization Application and launch preparations for X-linked Adrenoleukodystrophy (X-ALD) therapy
Minoryx is a clinical stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. The company’s lead program, leriglitazone (MIN-102), a novel, brain penetrant and selective PPARγ agonist, is being developed in X-linked Adrenoleukodystrophy (X-ALD) and other CNS diseases such as Friedreich’s ataxia.
Caixa Capital Risc, the venture capital arm of CriteriaCaixa and lead investor through its Criteria Venture Tech fund, and Iberdrola, through Perseo, its start-ups program for start-ups to promote the development of technology-based companies, have joined forces to accelerate the digitization of smart grids and cybersecurity with a €2.5 million ($2.6M) investment round in Barbara IoT. […]